{"id":"https://openalex.org/W1918769578","doi":"https://doi.org/10.1002/gps.2562","title":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","display_name":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-24","ids":{"openalex":"https://openalex.org/W1918769578","doi":"https://doi.org/10.1002/gps.2562","mag":"1918769578","pmid":"https://pubmed.ncbi.nlm.nih.gov/20872778"},"language":"en","primary_location":{"id":"doi:10.1002/gps.2562","doi":"https://doi.org/10.1002/gps.2562","is_oa":false,"landing_page_url":"https://doi.org/10.1002/gps.2562","pdf_url":null,"source":{"id":"https://openalex.org/S77085303","display_name":"International Journal of Geriatric Psychiatry","issn_l":"0885-6230","issn":["0885-6230","1099-1166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Geriatric Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1918769578"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027736490","display_name":"Gareth Maher\u2010Edwards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gareth Maher-Edwards","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK. Gareth.C.Maher-Edwards@gsk.com","GlaxoSmithKline; Uxbridge Middlesex UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK. Gareth.C.Maher-Edwards@gsk.com","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline; Uxbridge Middlesex UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ruth Dixon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ruth Dixon","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Herts, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Herts, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103494828","display_name":"Jackie A. Hunter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jackie Hunter","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Herts, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Herts, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Gold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Gold","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034933236","display_name":"Gillian Hopton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gillian Hopton","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Herts, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Herts, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066824740","display_name":"Gemma Jacobs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gemma Jacobs","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035923988","display_name":"Jo Hunter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jo Hunter","raw_affiliation_strings":["GlaxoSmithKline, Uxbridge, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Uxbridge, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089633973","display_name":"Pauline M. Williams","orcid":"https://orcid.org/0000-0001-9906-6226","observed_orcids":["https://orcid.org/0000-0001-9906-6226"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pauline Williams","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Herts, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Herts, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027736490"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":1.9262,"has_fulltext":false,"cited_by_count":114,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83919024,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"26","issue":"5","first_page":"536","last_page":"544"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.20640000700950623,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.06199999898672104,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.9509999752044678},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.5789999961853027},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6539999842643738},{"id":"https://openalex.org/keywords/global-function","display_name":"global function","score":0.6389999985694885},{"id":"https://openalex.org/keywords/adas-cog","display_name":"ADAS-Cog","score":0.968999981880188},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4690000116825104},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.9753953218460083},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8086724877357483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6104060411453247},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.541039228439331},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5186928510665894},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5148500800132751},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4874170124530792},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4726742208003998},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.43692445755004883},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.3612514138221741},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2279077172279358},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07098174095153809},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/gps.2562","doi":"https://doi.org/10.1002/gps.2562","is_oa":false,"landing_page_url":"https://doi.org/10.1002/gps.2562","pdf_url":null,"source":{"id":"https://openalex.org/S77085303","display_name":"International Journal of Geriatric Psychiatry","issn_l":"0885-6230","issn":["0885-6230","1099-1166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Geriatric Psychiatry","raw_type":"journal-article"},{"id":"pmid:20872778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20872778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of geriatric psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W31749136","https://openalex.org/W1164896577","https://openalex.org/W1847168837","https://openalex.org/W1895538680","https://openalex.org/W1953027527","https://openalex.org/W1981382028","https://openalex.org/W1985528178","https://openalex.org/W1998299683","https://openalex.org/W2004444318","https://openalex.org/W2016530927","https://openalex.org/W2023235142","https://openalex.org/W2031164126","https://openalex.org/W2039294854","https://openalex.org/W2055727638","https://openalex.org/W2072249708","https://openalex.org/W2076488791","https://openalex.org/W2081285591","https://openalex.org/W2087382128","https://openalex.org/W2099271519","https://openalex.org/W2102343148","https://openalex.org/W2107327698","https://openalex.org/W2109031511","https://openalex.org/W2109891655","https://openalex.org/W2111963393","https://openalex.org/W2112150247","https://openalex.org/W2117134611","https://openalex.org/W2121476689","https://openalex.org/W2156220037","https://openalex.org/W2745524785","https://openalex.org/W3150026755","https://openalex.org/W4251146972","https://openalex.org/W4291987942","https://openalex.org/W4300603082"],"related_works":["https://openalex.org/W1604099394","https://openalex.org/W2068669123","https://openalex.org/W4243062371","https://openalex.org/W1989525227","https://openalex.org/W2048061133","https://openalex.org/W1999018607","https://openalex.org/W2006552935","https://openalex.org/W2081285591","https://openalex.org/W2150645876","https://openalex.org/W2057679568"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"estimate":[2],"the":[3,50,76],"treatment":[4,35,99,126],"effects":[5],"of":[6,43],"SB-742457":[7,83,116,144,164,180],"and":[8,32,49,95,117,145,156,165,181],"donepezil":[9,89,166,182],"in":[10,14,75,101,130,171,189],"Alzheimer":[11],"disease":[12],"(AD)":[13],"a":[15,26],"contemporary":[16],"clinical":[17,191],"trial.":[18],"METHOD:":[19],"Randomized,":[20],"controlled,":[21],"parallel-group,":[22],"exploratory":[23,162],"study":[24],"with":[25,45,63,169,193],"4-week,":[27],"single-blind,":[28],"placebo":[29],"run-in":[30],"phase":[31],"24-week,":[33],"double-blind":[34],"phase.":[36],"Primary":[37],"endpoints":[38],"were":[39,70,73,107,139,153,167],"Clinician's":[40],"Interview-Based":[41],"Impression":[42],"Change":[44],"caregiver":[46],"input":[47],"(CIBIC+)":[48],"Alzheimer's":[51],"Disease":[52],"Assessment":[53],"Scale-cognitive":[54],"subscale":[55],"(ADAS-Cog).":[56],"RESULTS:":[57],"One":[58],"hundred":[59],"ninety":[60],"eight":[61],"subjects":[62],"mild-to-moderate":[64],"probable":[65],"AD":[66],"(MMSE":[67],"scores":[68],"12-26)":[69],"randomized;":[71],"196":[72],"included":[74],"intent-to-treat":[77],"population":[78],"(placebo,":[79],"n":[80,86,92],"=":[81,87,93],"61;":[82],"35":[84],"mg/day,":[85,91],"68;":[88],"10":[90],"67),":[94],"161":[96],"completed.":[97],"Drug-placebo":[98,125],"differences":[100,127],"CIBIC+":[102],"score":[103,135],"at":[104,136],"week":[105],"24":[106,138],"-0.17":[108],"(90%":[109,119,128],"confidence":[110],"interval":[111],"[CI]:":[112],"-0.50,":[113],"0.16)":[114],"for":[115,123,143,149,178],"-0.28":[118],"CI:":[120],"-0.61,":[121],"0.05)":[122],"donepezil.":[124,150,194],"CI)":[129],"change":[131],"from":[132],"baseline":[133],"ADAS-Cog":[134],"Week":[137],"-0.4":[140],"(-2.2,":[141],"1.4)":[142],"-1.2":[146],"(-3.0,":[147],"0.6)":[148],"All":[151],"treatments":[152],"generally":[154],"safe":[155],"well":[157],"tolerated.":[158],"CONCLUSIONS:":[159],"In":[160],"this":[161],"study,":[163],"associated":[168],"improvements":[170],"global":[172],"function.":[173],"Treatment":[174],"effect":[175],"on":[176],"cognition":[177],"both":[179],"was":[183],"smaller":[184],"than":[185],"those":[186],"previously":[187],"observed":[188],"previous":[190],"studies":[192]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1918769578","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
